Study links endometriosis with increased risk of developing 3 specific types of ovarian cancer

February 21, 2012

Women with a history of endometriosis are significantly more likely to develop three specific types of ovarian cancer (clear cell, endometrioid, and low-grade serous), according to an article published Online First in the Lancet Oncology.

Although several small studies have suggested that endometriosis (a common gynaecological disorder that affects about 10% of women of reproductive age) is associated with a risk of developing epithelial ovarian cancer (the most deadly and prevalent form), this study definitively confirms the magnitude of this risk and the relationship with specific subtypes.

"This breakthrough could lead to better identification of women at increased risk of ovarian cancer and could provide a basis for increased cancer surveillance of the relevant population, allowing better individualisation of prevention and early detection approaches such as risk-reduction surgery and screening", explains Celeste Leigh Pearce from the University of Southern California, Los Angeles, USA, lead author of the study.

In this study, a team from The Ovarian Cancer Association Consortium (OCAC) calculated the size of the association between endometriosis and the risk of the five major ovarian cancer histological subtypes separately (high-grade serous, low-grade serous, clear cell, endometrioid, and mucinous carcinomas). The study consisted of a pooled analysis of 13 case-control studies, which included data from over 23 000 women (13 326 controls, 7911 with invasive ovarian cancer, 1907 with borderline cancer).

The researchers estimated that endometriosis is linked to a more than threefold chance of developing clear-cell ovarian cancers, and is associated with more than double the risk of developing endometrioid tumours.

Importantly, for the first time an association between endometriosis and low-grade serous ovarian cancers was noted; translating to a doubling of the risk in women with a history of endometriosis.

No link was found between endometriosis and high-grade serous, mucinous, serous borderline, or mucinous borderline ovarian cancers.

The authors caution: "Although we have reported strong associations between endometriosis and risk of clear-cell, endometrioid, and low grade serous ovarian cancers, most women with endometriosis do not develop ovarian cancer. However, healthcare providers should be alert to the of specific subtypes of ovarian cancer in with a history of endometriosis."*

In an accompanying Comment, Charlie Gourley from University of Edinburgh Cancer Research UK Centre, Edinburgh, UK points out: "Although the risk of epithelial ovarian cancer shown by the results…is perhaps not in itself sufficient to justify targeted screening of patients with a history of , the fact that some of the associated histological subtypes (eg, clear-cell) predominantly present at an early stage (allowing possible curative resection) makes this a consideration."

Explore further: Role of known cancer gene in ovarian cancer investigated

Related Stories

Role of known cancer gene in ovarian cancer investigated

February 14, 2012
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia ...

Gene mutation discovery sparks hope for effective endometriosis screening

February 6, 2012
Researchers at Yale School of Medicine have, for the first time, described the genetic basis of endometriosis, a condition affecting millions of women that is marked by chronic pelvic pain and infertility. The researchers' ...

Researchers discover antibody that may help detect ovarian cancer in earliest stages

August 16, 2011
Using a new approach to developing biomarkers for the very early detection of ovarian cancer, researchers at Rush University Medical Center have identified a molecule in the bloodstream of infertile women that could one day ...

Recommended for you

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

Physical activity could combat fatigue, cognitive decline in cancer survivors

July 25, 2017
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.

Breaking the genetic resistance of lung cancer and melanoma

July 25, 2017
Researchers from Monash University and the Memorial Sloan Kettering Cancer Center (MSKCC, New York) have discovered why some cancers – particularly lung cancer and melanoma – are able to quickly develop deadly resistance ...

New therapeutic approach for difficult-to-treat subtype of ovarian cancer identified

July 24, 2017
A potential new therapeutic strategy for a difficult-to-treat form of ovarian cancer has been discovered by Wistar scientists. The findings were published online in Nature Cell Biology.

Immune cells the missing ingredient in new bladder cancer treatment

July 24, 2017
New research offers a possible explanation for why a new type of cancer treatment hasn't been working as expected against bladder cancer.

Anti-cancer chemotherapeutic agent inhibits glioblastoma growth and radiation resistance

July 24, 2017
Glioblastoma is a primary brain tumor with dismal survival rates, even after treatment with surgery, chemotherapy and radiation. A small subpopulation of tumor cells—glioma stem cells—is responsible for glioblastoma's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.